Eberconazole

• CAT Number: M111622
• CAS Number: 128326-82-9
• Molecular Formula: C18H14Cl2N2
• Molecular Weight: 329.24
• Purity: ≥95%
• Storage: Desiccate at -20C
• IUPAC Name: 1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole
• InChI: InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2
• InChIKey: MPTJIDOGFUQSQH-UHFFFAOYSA-N
• SMILES: C1CC2=C(C(C3=CC=CC=C31)N4C=CN=C4)C(=CC(=C2)Cl)Cl

Eberconazole（Cat No.:M111622）is a potent antifungal agent used in the treatment of dermatophytosis, candidiasis, and other superficial fungal infections. It works by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes, thereby disrupting cell membrane integrity and function. Eberconazole is typically formulated in topical preparations for the effective management of skin and mucosal infections. Its broad-spectrum activity, low toxicity, and localized application make it a valuable option in dermatological antifungal therapy, offering targeted treatment with minimal systemic absorption. Ideal for treating fungal infections on the skin and mucous membranes.